Aytu Biopharma, Inc
AYTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385818
No open-market purchases or sales by Aytu Biopharma, Inc insiders were filed in the last 90 days; 38 institutions reported holding it in 13F filings for Q2 2026, worth $8.25M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Aytu Biopharma, Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q2 2023
- Shares held
- 1.73M
- +20.8K (+1.2%) vs. Q2 2023
- Total value
- $4.65M
- +$1.93M (+70.7%) vs. Q2 2023
- New holders
- 3
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AYTU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 38 | $8.25M |
| Q1 2026 | 37 | $10.7M |
| Q4 2025 | 39 | $9.81M |
| Q3 2025 | 33 | $6.73M |
| Q2 2025 | 32 | $7.45M |
| Q1 2025 | 31 | $2.49M |
| Q4 2024 | 29 | $3.19M |
| Q3 2024 | 24 | $4.81M |
| Q2 2024 | 27 | $5.99M |
| Q1 2024 | 27 | $5.46M |
| Q4 2023 | 22 | $5.02M |
| Q3 2023 | 22 | $4.65M |
| Q2 2023 | 21 | $2.73M |
| Q1 2023 | 21 | $1.21M |
| Q4 2022 | 42 | $1.52M |
| Q3 2022 | 53 | $1.64M |
| Q2 2022 | 41 | $2.50M |
| Q1 2022 | 44 | $6.02M |
| Q4 2021 | 46 | $5.10M |
| Q3 2021 | 49 | $12.2M |
| Q2 2021 | 61 | $26.0M |
| Q1 2021 | 72 | $48.4M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aytu Biopharma, Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ronald Blue Trust, Inc. | 278 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 151 | $0 | 0.00% | −121−44.5% | Reduced |
| FMR LLC | 4 | $11 | 0.00% | −1−20.0% | Reduced |
| CarsonAllaria Wealth Management, Ltd. | 5 | $14 | 0.00% | +5 | New |
| GWM Advisors LLC | 21 | $57 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 37 | $100 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 110 | $297 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 157 | $423 | 0.00% | −1−0.6% | Reduced |
| Advisor Group Holdings, Inc. | 301 | $813 | 0.00% | −2−0.7% | Reduced |
| Morgan Stanley | 1,400 | $3.78K | 0.00% | +960+218.2% | Added |
| JPMorgan Chase & Co | 2,188 | $5.91K | 0.00% | +1,601+272.7% | Added |
| UBS Group AG | 4,164 | $11.2K | 0.00% | +3,904+1,501.5% | Added |
| Tower Research Capital LLC (TRC) | 5,754 | $15.5K | 0.00% | −1,418−19.8% | Reduced |
| Vanguard Group Inc | 12,973 | $35.0K | 0.00% | +12,973 | New |
| Northern Trust Corp | 14,568 | $39.3K | 0.00% | +14,568 | New |
| Geode Capital Management, LLC | 16,535 | $44.7K | 0.00% | +4,639+39.0% | Added |
| Acadian Asset Management LLC | 22,537 | $59.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 24,059 | $65.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 60,723 | $164.0K | 0.00% | +3,400+5.9% | Added |
| Stonepine Capital Management, LLC | 472,369 | $1.28M | 0.42% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,086,812 | $2.93M | 0.37% | 00.0% | Unchanged |
| TSFG, LLC | 1 | – | – | 00.0% | Unchanged |
| Prudential Financial Inc | 0 | $0 | 0.00% | −19,576−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −177−100.0% | Sold out |